The Effect of Ropinirole on the Quality of Life in Patients with Restless Legs Syndrome in Korea: An 8-Week, Multicenter, Prospective Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Yong Won | - |
dc.contributor.author | Hong, Seung Bong | - |
dc.contributor.author | Kim, Do Hyung | - |
dc.contributor.author | Lee, Ho Won | - |
dc.contributor.author | Joo, Eun Yeon | - |
dc.contributor.author | Kim, Jee Hyun | - |
dc.contributor.author | Shin, Won Chul | - |
dc.contributor.author | Park, Kee Hyung | - |
dc.contributor.author | Han, Sun Jung | - |
dc.contributor.author | Lee, Hyang Woon | - |
dc.date.available | 2020-02-29T00:46:14Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013-01 | - |
dc.identifier.issn | 1738-6586 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14837 | - |
dc.description.abstract | Background and Purpose Dopamine agonists are first-line drugs for treating the symptoms of restless legs syndrome (RLS). However, few studies have investigated the effect of dopamine agonists on the quality of life (QoL) in RLS patients. We conducted a study to determine whether ropinirole exerts positive effects on the QoL in RLS patients and to analyze the underlying factors. Methods Primary RLS patients from eight medical centers were recruited in the study. They were evaluated in the baseline phase using various questionnaires including the Korean versions of the International Restless Legs Scale (K-IRLS), RLS QoL questionnaire (K-RLSQoL), and the Short Form 36 Health Survey (SF-36). After taking ropinirole for 8 weeks the same questionnaires were again completed as a re-evaluation. We analyzed the statistical difference using a paired 1-test, a Pearson's correlation, and a stepwise multiple regression in order to identify the factors associated with the QoL change. Results A total of 107 subjects, including 65 (60.7%) females, completed this study. They were aged 51.68 +/- 14.80 years (mean +/- SD) and had a symptom duration of 8.8 +/- 9.0 months. After treatment with ropinirole, there were significant improvements on the K-RLSQoL, SF-36, and K-IRLS. The Pearson's correlation analysis showed that the improvement of QoL in RLS patients was significantly correlated with the severity of RLS (r=0.236, p<0.014) at baseline. Conclusions The results from this study suggest that treatment with ropinirole can improve the QoL in RLS patients. The improvement in the QoL is more related with the improvement of RLS symptoms. J Clin Neurol 2013;9:51-56 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROLOGICAL ASSOC | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL NEUROLOGY | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | EPIDEMIOLOGY | - |
dc.subject | PREVALENCE | - |
dc.subject | SLEEP | - |
dc.subject | RISK | - |
dc.subject | POPULATION | - |
dc.subject | DIAGNOSIS | - |
dc.subject | MOVEMENTS | - |
dc.subject | SEVERITY | - |
dc.subject | EFFICACY | - |
dc.title | The Effect of Ropinirole on the Quality of Life in Patients with Restless Legs Syndrome in Korea: An 8-Week, Multicenter, Prospective Study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000313137200009 | - |
dc.identifier.doi | 10.3988/jcn.2013.9.1.51 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL NEUROLOGY, v.9, no.1, pp.51 - 56 | - |
dc.identifier.kciid | ART001734895 | - |
dc.identifier.scopusid | 2-s2.0-84887841525 | - |
dc.citation.endPage | 56 | - |
dc.citation.startPage | 51 | - |
dc.citation.title | JOURNAL OF CLINICAL NEUROLOGY | - |
dc.citation.volume | 9 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Park, Kee Hyung | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | restless legs syndrome | - |
dc.subject.keywordAuthor | dopamine agonists | - |
dc.subject.keywordAuthor | quality of life | - |
dc.subject.keywordAuthor | sleep | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | SLEEP | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | MOVEMENTS | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.